Am Fam Physician. 2015 Nov 1;92(9):820.
What is the comparative effectiveness of citalopram (Celexa), methylphenidate (Ritalin), or both for the treatment of depression among older patients?
Combined treatment with citalopram plus methylphenidate provided faster improvement of depression symptoms in older patients with unipolar depression. Combined treatment was also more likely than either medication alone to lead to remission of depression at four weeks and 16 weeks. The study was too small to assess clinically meaningful differences in rare adverse drug effects. Because there was no dose-response effect with titration of the methylphenidate, a low dose (e.g., 5 mg twice daily) seems prudent. (Level of Evidence = 1b)
This randomized controlled trial of older patients with depression compared citalopram plus placebo (n = 48), methylphenidate plus
POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP,search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.
A collection of POEMs published in AFP is available at http://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions